We are live on
!
Find out more
GCA
Greenwood Capital Associates Portfolio holdings
AUM
$1.02B
1-Year Est. Return
28.26%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$804M
AUM Growth
+$62.4M
(+8.4%)
Cap. Flow
+$3.16M
Cap. Flow
% of AUM
0.39%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
264
New
30
Increased
63
Reduced
144
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$14.3M |
| 2 |
ASML
ASML
|
+$4.88M |
| 3 |
Advanced Micro Devices
AMD
|
+$4.38M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$3.87M |
| 5 |
UnitedHealth
UNH
|
+$3.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$6.84M |
| 2 |
Dell
DELL
|
+$4.44M |
| 3 |
Micron Technology
MU
|
+$3.99M |
| 4 |
IBM
IBM
|
+$2.52M |
| 5 |
Medtronic
MDT
|
+$2.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.31% |
| 2 | Financials | 11.52% |
| 3 | Healthcare | 8.37% |
| 4 | Communication Services | 6.65% |
| 5 | Industrials | 6.08% |
Similar funds
SVCP
EFM
CC
MSA
MAM
IAS
WA
GA
Greenwood Capital Associates's Q2 2025 Portfolio in Review
As of Q2 2025, Greenwood Capital Associates held 264 positions worth $804M, up 8.4% from $741M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Greenwood Capital Associates's Q2 2025 filing shows 30 new, 63 increased, 144 reduced and 15 closed positions. Its largest new stake was ASML: 6,795 shares worth $5.45M. The largest sale was Merck, an estimated $6.84M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Greenwood Capital Associates's largest Q2 2025 buy was ASML: 6,795 shares worth $5.45M.
- Greenwood Capital Associates added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $14.3M increase.
- Greenwood Capital Associates's biggest Q2 2025 reduction was IBM, cutting an estimated $2.52M.
- Greenwood Capital Associates fully exited Merck in Q2 2025, selling an estimated $6.84M.
- Greenwood Capital Associates's ten largest holdings make up 28% of its $804M portfolio in Q2 2025.
- Greenwood Capital Associates opened 30 new positions and closed 15 in Q2 2025.
- Greenwood Capital Associates's portfolio value rose 8.4% quarter-over-quarter to $804M.
Based on Greenwood Capital Associates's 13F filing for Q2 2025, filed 21 Jul 2025.